HighTower Advisors
RKDA icon

HighTower Advisors’s Arcadia Biosciences RKDA Stock Holding History

HighTower Advisors’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,597
Closed -$16K – 3630
2022
Q4 		$16K Buy
1,597
+528
+49% +$7.52K ﹤0.01% 3145
2022
Q3 		$23K Buy
1,069
+25
+2% +$853 ﹤0.01% 2961
2022
Q2 		$41K Sell
1,044
-3
-0.3% -$138 ﹤0.01% 2925
2022
Q1 		$59K Buy
1,047
+20
+2% +$954 ﹤0.01% 3056
2021
Q4 		$43K Buy
1,027
+193
+23% +$12.6K ﹤0.01% 3039
2021
Q3 		$70K Buy
834
+55
+7% +$5.16K ﹤0.01% 2898
2021
Q2 		$92K Buy
779
+270
+53% +$29.4K ﹤0.01% 2824
2021
Q1 		$56K Hold
509
– – ﹤0.01% 2820
2020
Q4 		$51K Hold
509
– – ﹤0.01% 2408
2020
Q3 		$57K Buy
509
+178
+54% +$24K ﹤0.01% 2296
2020
Q2 		$50K Buy
+331
New +$51.5K ﹤0.01% 2198

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HighTower Advisors's RKDA Position: Q1 2023 in Review

HighTower Advisors sold out of Arcadia Biosciences (RKDA) in Q1 2023, closing a stake of 1,597 shares — an estimated $16K sold.

HighTower Advisors first reported a position in RKDA in Q2 2020 and held it in 11 quarters. The position peaked at $92K in Q2 2021. 15 funds tracked by Wall St. Rank hold RKDA as of Q1 2023.

  • HighTower Advisors reported no remaining Arcadia Biosciences position as of Q1 2023 after selling out during the quarter.
  • HighTower Advisors sold 1,597 Arcadia Biosciences shares in Q1 2023, an estimated $16K.
  • HighTower Advisors first reported a position in Arcadia Biosciences in Q2 2020 and held it in 11 quarters.
  • HighTower Advisors's Arcadia Biosciences position peaked at $92K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2023.

Based on HighTower Advisors's 13F filing for Q1 2023, filed 12 May 2023.